Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Uterine Cervical Neoplasms 2Condylomata Acuminata 2Vomiting 1Nausea 1Breast Neoplasms 1

Interventions

Dexamethasone 23Ondansetron 12Palonosetron 11Aprepitant 9Granisetron 7Olanzapine 5ramosetron 3netupitant, palosentron drug combination 3casopitant 3Radiotherapy 3fosaprepitant 2Thalidomide 2Prochlorperazine 2Electroacupuncture 2Dronabinol 2Analgesia 2Acupressure 2sinomenine 1netupitant 1lerisetron 1dolasetron 1dexamethasone acetate 1Tropisetron 1Therapeutics 1Taxes 1Tablets 1Surveys and Questionnaires 1Sugars 1Metoclopramide 1Hygiene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Vomiting × Duration of Therapy × Clear all
NCT00092196 2017-05-05

Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED)

Merck Sharp & Dohme LLC

Phase 3 Completed
820 enrolled
Breast

Breast Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡